Reshaping an already inflated🎈to use it again? It's possible, easy, green & economical! Just follow Dr. Ángel G. Nájera Albarrán & Neisser M's advice! #cardioed #cardiotwitter #meded 👉 tinyurl.com/4vwt3cvp

Great tips for coiling type 5 coronary perfs. Note hand position. Normal wire can be used. If coil rip curls up it's out of vessel- that's when you pull back your finecross. Goal is to have small coiled part outside, rest (straight )in vessel. #CTO2024

ST-Elevation with dual injection in CTO PCI. Good example to keep your eye on the ECG and maybe opt for sequential injections #CTO2024

Calls into question the QoL benefit in TRISCEND II & TRILUMINATE open label trials without placebo control which drove PEP in these trials & regulatory approval.   What is the role of interatrial shunting in HF given null results in RELIEVE-HF and REDUCE-LAP HF II?

Gosh, I was surprised to see this ad for a medical device that might be beneficial in very specific circumstances and has substantial risks. It showed up in my The New York Times feed. Seems to lack any nuance. The U.S. FDA approved this ad?

MN ECMO Pinnacle Symposium An amazing 2 days with inspiring friends. Fascinating breadth- breaking dogma with PV loops, delayed waking & neuroprog post ECPR arrest, donation potential, new oxygenation tech Demetris Yannopoulos Charles Bruen Dr. Jason Bartos sites.google.com/umn.edu/ecmofu…

Asymptomatic Severe AS: LBCT TCT Conference 2024 includes Early TAVR and EVOLVED. See recent AVATAR Trial F/U bit.ly/AVATAR_FU TCTMD Philippe Pibarot David J. Cohen, MD, MSc American College of Cardiology European Society of Cardiology European Society of Cardiology Journals NEJM

Highly innovative experiment in Circulation using plasmapheresis shows that the half life of troponin is much shorter than previously thought. This means troponin is released after MI for longer than previously believed. ahajournals.org/doi/full/10.11…

When we are talking about mobile ECMO we really talking about Mobile ECMO ! No messing around !

Just read this viewpoint from re-known authors regarding asymptomatic aortic stenosis. As expected I disagree 200% and feel the ground is being pushed for an unfortunate guideline modification. My reasons….(1/x) jamanetwork.com/journals/jamac…

Fascinating article with implications for more than just EP-doctors: More cerebral impacts from aortic/arterial vs trans septal route ahajournals.org/doi/full/10.11…

"Authors report no relationships relevant to the contents" WHAT? Roberta Bogaev is an employee of Abiomed. Lindenfeld got $2400 in honoraria from Abiomed in 2024. Lala got $8400 in honoraria in 2024. Paper should be retracted. @biykemB Christopher O'Connor Vanessa Blumer, MD, FACC, FHFSA

Instructions to set this up for yourself: bnrc.springeropen.com/articles/10.11… thanks to Visible Heart® Laboratories

Learning from the best! Dr Bartos on new & exciting trials 🔬🧪 ♥️Detection is 🗝️ ♥️DSC as 1st ⚡️ vs standard ♥️Bicarb, 🩸🩸 being investigated ♥️eCPR data coming soon #CritCareCards25 Society Of Critical Care Cardiology CCC Enthusiasts Jason N. Katz James Horowitz Ann Gage

#TCT2025 DEB vs DES in de novo lesion! SELUTION trial. Deb is Non inferior to DES. This is going to be future. Stents are great but no metal left behind in 2-5 mm vessels is the way to go. #CardioX #CardioTwitter #CardioEd #CardioResearch Dan Burkhoff MD PhD David J. Cohen, MD, MSc Carlos Collet MD PhD

I tried to tell you

Our beliefs about LAAC should have been pessimistic going into the trial: CLOSURE AF finds extremely pessimistic data—which only strengthen these priors. open.substack.com/pub/sensibleme… via John Mandrola, MD